← Back to home
Comparison · Analytics

forcis vs pharmaverseadam

A side-by-side editorial comparison of forcis and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.

forcis vs pharmaverseadam: at a glance

Featureforcispharmaverseadam
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdata-access, r-package, ropensci, oceanographypharmaverse, clinical-data, adam, test-data
Last editorial update48m ago2h ago
WebsiteVisit →Visit →

What is forcis?

A foraminifera data-access package whose entire release history is the rOpenSci review process.

forcis provides R access to the FORCIS database of planktonic foraminifera occurrences. All three releases in the window are review milestones rather than feature work: first stable release, the release answering rOpenSci reviewer comments, and a post-CRAN-review polish. Release notes point at NEWS.md rather than enumerating changes.

Read the full forcis trajectory →

What is pharmaverseadam?

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

Read the full pharmaverseadam trajectory →

forcis vs pharmaverseadam: editorial side-by-side

F
forcis
ANALYTICS
0.0

A foraminifera data-access package whose entire release history is the rOpenSci review process.

◆ Current state

forcis provides R access to the FORCIS database of planktonic foraminifera occurrences. All three releases in the window are review milestones rather than feature work: first stable release, the release answering rOpenSci reviewer comments, and a post-CRAN-review polish. Release notes point at NEWS.md rather than enumerating changes.

◆ Where it's heading

The package is moving from research artifact to reviewed, distributable infrastructure — submitted to rOpenSci at 0.1.0, integrated review feedback at 1.0.0, cleared CRAN at 1.0.1. That arc is complete, so the next phase should be the first release driven by users rather than reviewers.

◆ Prediction

With review and CRAN acceptance both behind it, the next release is most likely to track upstream FORCIS database changes or add query conveniences; the entries themselves say nothing about planned features.

P0.0

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

◆ Current state

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

◆ Where it's heading

Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.

◆ Prediction

Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.

Alternatives to forcis and pharmaverseadam

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either forcis or pharmaverseadam.

See all forcis alternatives → · See all pharmaverseadam alternatives →

Recent activity from forcis and pharmaverseadam

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
  2. 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
  3. 1y agoforcisPost-CRAN-review example and practice cleanup
  4. 1y agoforcis1.0.0 incorporates rOpenSci review feedback
  5. 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
  6. 1y agoforcisFirst stable release, submitted to rOpenSci
  7. 2y agopharmaverseadam1.0 declares the dataset collection stable
  8. 2y agopharmaverseadamFirst release of the ADaM dataset collection

Frequently asked questions

What is the difference between forcis and pharmaverseadam?

They serve adjacent needs but don't currently overlap on shipped themes. forcis and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is forcis better than pharmaverseadam?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. forcis and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to forcis?

Top forcis alternatives in Analytics are ranked by recent ship velocity. Browse the "forcis alternatives" section above for the current picks, or visit /alternatives/forcis for the full list with editorial commentary on each.

What are the best alternatives to pharmaverseadam?

Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.